Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients

Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients Publisher Pubmed

Saffarian Z^{1, 2} ; Samii R² ; Hadizadeh A³ ; Ghanadan A⁴ ; Vahidnezhad H^{5, 6}

Show Affiliations

1. Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran
2. Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
3. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Pathology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
5. Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States
6. Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA, United States

Source: Dermatologic Therapy Published:2022

Abstract

[No abstract available]

Related Docs

1. Covid-19: A Trigger of Autoimmune Diseases, Cell Biology International (2023)

2. Anticoagulant Therapy in Covid-19: A Narrative Review, Clinical and Translational Science (2023)

3. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)

4. De Novo Severe Pemphigus Vulgaris Following Sars-Cov-2 Vaccination With Bbibp-Corv, Dermatologic Therapy (2022)

5. A Systematic Review of Histopathologic Surveys on Mucocutaneous Biopsies in Patients Developed Covid-19 Vaccine-Related Dermatologic Manifestations, American Journal of Dermatopathology (2023)

6. Venous Thromboembolism in Viral Diseases: A Comprehensive Literature Review, Health Science Reports (2023)

Experts (# of related papers)

View all Related Experts

Alireza Ghanadan (1)

Zahra Saffarian (1)

Style	Citing Format
MLA	Saffarian Z, et al.. "Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients." Dermatologic Therapy, vol. 35, no. 11, 2022, pp. -.
APA	Saffarian Z, Samii R, Hadizadeh A, Ghanadan A, Vahidnezhad H (2022). Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients. Dermatologic Therapy, 35(11), -.
Chicago	Saffarian Z, Samii R, Hadizadeh A, Ghanadan A, Vahidnezhad H. "Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients." Dermatologic Therapy 35, no. 11 (2022): -.
Harvard	Saffarian Z et al. (2022) 'Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients', Dermatologic Therapy, 35(11), pp. -.
Vancouver	Saffarian Z, Samii R, Hadizadeh A, Ghanadan A, Vahidnezhad H. Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients. Dermatologic Therapy. 2022;35(11):-.
BibTex	@article{ author = {Saffarian Z and Samii R and Hadizadeh A and Ghanadan A and Vahidnezhad H}, title = {Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients}, journal = {Dermatologic Therapy}, volume = {35}, number = {11}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Saffarian Z AU - Samii R AU - Hadizadeh A AU - Ghanadan A AU - Vahidnezhad H TI - Purpuric Dermatosis and Lymphocytic Vasculopathy Following Sars-Cov-2 Vaccination: Report of Two Patients JO - Dermatologic Therapy VL - 35 IS - 11 SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract